ZINTREXYL-C- ferrous fumarate, folic acid tablet USA - engelska - NLM (National Library of Medicine)

zintrexyl-c- ferrous fumarate, folic acid tablet

puretek corporation - vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), p - zintrexyl-c tm is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. also for the treatment of the condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

FOLTREXYL- folic acid, vitamin d3 tablet USA - engelska - NLM (National Library of Medicine)

foltrexyl- folic acid, vitamin d3 tablet

puretek corporation - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41) - foltrexyl™ is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels and vitamin d supplementation. foltrexyl™ can be taken by women of childbearing age, pregnant women, and lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients. foltrexyl™ is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

VITREXYL- folic acid tablet USA - engelska - NLM (National Library of Medicine)

vitrexyl- folic acid tablet

puretek corporation - .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), molybdenum (unii: 81ah48963u) (molybdenum - unii:81ah48963u), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77 - vitrexyl™ is indicated to provide vitamin supplement to men and women. folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

VITREXYL PLUS IRON- ferrous fumarate, folic acid tablet USA - engelska - NLM (National Library of Medicine)

vitrexyl plus iron- ferrous fumarate, folic acid tablet

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - vitrexyl + iron is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, alongwith a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well ascases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

AMPITREXYL- andrographis paniculata whole capsule USA - engelska - NLM (National Library of Medicine)

ampitrexyl- andrographis paniculata whole capsule

promex llc - andrographis paniculata whole (unii: 0p49l952wz) (andrographis paniculata whole - unii:0p49l952wz) - andrographis paniculata whole 500 mg - maximum recommended daily dosage of ampitrexyl is 3 servings per day for adults, preferably with a meal.

CEFATREXYL Withdrawn Form 500 Milligram Irland - engelska - HPRA (Health Products Regulatory Authority)

cefatrexyl withdrawn form 500 milligram

bristol-myers squibb (holdings) limited - cefapirin sodium - withdrawn form - 500 milligram

CEFATREXYL Withdrawn Form 1 g/100ml Irland - engelska - HPRA (Health Products Regulatory Authority)

cefatrexyl withdrawn form 1 g/100ml

bristol-myers squibb (holdings) limited - cefapirin sodium - withdrawn form - 1 g/100ml

PENTREXYL Capsule 250 Milligram Irland - engelska - HPRA (Health Products Regulatory Authority)

pentrexyl capsule 250 milligram

bristol-myers squibb (holdings) limited - ampicillin trihydrate - capsule - 250 milligram

PENTREXYL Capsule 500 Milligram Irland - engelska - HPRA (Health Products Regulatory Authority)

pentrexyl capsule 500 milligram

bristol-myers squibb (holdings) limited - ampicillin trihydrate - capsule - 500 milligram

PENTREXYL Withdrawn Form 250 Milligram Irland - engelska - HPRA (Health Products Regulatory Authority)

pentrexyl withdrawn form 250 milligram

bristol-myers squibb (holdings) limited - ampicillin sodium - withdrawn form - 250 milligram